Evidence map›Paper›PMID 42116662›Full record

ArticleEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2026

Pulsed field ablation vs. thermal ablation for pulmonary vein isolation: a network meta-analysis of randomized controlled trials.

Alessia Chiara Latini, Mattia Penna, Andrea Saglietto, Federico Landra, Mauro Chiarito, Alessandro Villaschi, Gaia Filiberti, Sebastiano Carli, Stefano Valcher, Chiara Valeriano and 7 more

Abstract readNetwork Meta-Analysis
In one paragraph

Article in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Alessia Chiara LatiniDepartment of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy.ORCID 0000-0002-6024-6278
Mattia PennaDepartment of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy.ORCID 0009-0003-3633-5670
Andrea SagliettoDivision of Cardiology, 'Città Della Salute e Della Scienza di Torino' Hospital, Department of Medical Sciences, University of Turin, Turin 10126, Italy.ORCID 0000-0001-9475-1507
Federico LandraAzienda Ospedaliera S. Croce e Carle, Cuneo, Italy.ORCID 0000-0002-2106-0884
Mauro ChiaritoDepartment of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy.ORCID 0000-0002-9333-2658
Alessandro VillaschiDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele 20072, Milan, Italy.ORCID 0000-0002-7981-7894
Gaia FilibertiDepartment of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy.ORCID 0009-0002-8767-8895
Sebastiano CarliDepartment of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy.ORCID 0009-0001-6178-879X
Stefano ValcherDepartment of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy.ORCID 0000-0001-8355-9894
Chiara ValerianoDepartment of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy.ORCID 0000-0002-0130-6218
Francesco AmataDepartment of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy.ORCID 0000-0003-3651-6765
Aurora SannitiDepartment of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy.ORCID 0000-0001-6483-9508
Cristina PanicoDepartment of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy.ORCID 0000-0002-9198-3676
Stefano FigliozziDepartment of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy.ORCID 0000-0003-2991-1548
Massimo Vito TrittoDepartment of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy.ORCID 0000-0003-0101-0908
Gianluigi CondorelliDepartment of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy.ORCID 0000-0003-0481-6843
Diego PenelaDepartment of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy.ORCID 0009-0009-7221-4829

Funding

Humanitas Research Hospital
6 · The paper itself

Abstract

aimsPulsed field ablation (PFA) has recently emerged as a promising alternative to conventional energy sources (ES) for atrial fibrillation (AF) ablation. However, comparative data between PFA and other ES-such as radiofrequency (RFA), cryoballoon (CBA), and laser balloon ablation (LBA)-remain limited.This network meta-analysis (CRD420251054760) aimed to compare outcomes of PFA vs. thermal ES for AF ablation. METHODS AND

resultsA systematic network meta-analysis using PubMed, Cochrane, and EMBASE from inception to March 2026 was performed. Randomized controlled trials comparing different ES in first-attempt pulmonary vein isolation were included. Data extraction was performed according to PRISMA guidelines. The primary outcome was the recurrence of any sustained atrial tachyarrhythmia (ATA) at 12-month follow-up. Safety and efficiency outcomes were also compared among groups. We included 18 studies, encompassing 4162 patients. Compared to PFA, thermal ablation technologies showed a higher risk of ATA recurrence at 12-month follow-up (RFA: RR of 1.48 (95% CI 1.10-2.00); CBA: 1.43 (95% CI 1.07-1.92); LBA: RR 1.29 (CI 95% 0.84-1.98)). PFA exhibited the lowest procedural time among transcatheter ES, whereas RFA displayed a significantly lower fluoroscopy time. No significant differences were recorded for major periprocedural complications. A subgroup analysis restricted to studies involving only paroxysmal AF patients, as well as those employing contemporary technologies, yielded consistent findings.

conclusionThe present data indicate that, in patients undergoing a first transcatheter AF ablation, PFA may be associated with favourable efficacy and procedural efficiency compared with traditional thermal technologies, while showing a broadly comparable safety profile.

Indexed as

Atrial FibrillationCatheter AblationPulmonary VeinsHumansRandomized Controlled Trials as TopicRecurrenceTreatment OutcomeAtrial fibrillationNetwork metanalysisPulmonary vein isolationPulsed field ablationRecurrenceThermal ablation

Identifiers

PMID42116662
PMCPMC13256017

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.